Molecular Imaging Research Program

Mission

The goals of the Molecular Imaging (MI) Program include the development and testing of new imaging methods ranging from preclinical work on the synthesis of new probes and development of new devices to the clinical evaluation of imaging approaches to assess cancer risk, detect cancer, guide treatment and monitor therapy. These imaging methods are aimed at improving our understanding of cancer physiology and providing for the integration of these findings to ultimately improve the assessment of cancer and its treatment. To achieve these goals we have two themes. 

Scientific Themes

  • Theme 1. Synthesis of new imaging agents for metabolism and drug pharmacodynamics
  • Theme 2. Implement and test new imaging agents and methods for risk assessment, detection, guidance and assessment of the response to therapy
  • Theme 3. Develop and test novel instrumentation for molecular imaging

Program Activities

The MI Program works to bring investigators together to expand collaborative activities with members of our program and other programs through:

  • Monthly program meetings which include speakers from within the MI Program, speakers from related disciplines and invited outside speakers. 
  • Joint meetings or mini-retreats with other programs to highlight particular areas of collaboration. 
  • Yearly retreats are held for the program to further foster collaboration among members
  • Organization of working groups to evaluate joint projects including multi-investigator pilot projects, protocols, and grants. 

Program Leaders

  • Nerissa Viola, Ph.D.

    Leader, Molecular Imaging Program
    Karmanos Cancer Institute
    Wayne State University School of Medicine

  • Anthony Shields, M.D., Ph.D.

    Co-Leader, Molecular Imaging Program
    Karmanos Cancer Institute
    Wayne State University School of Medicine

The Latest From Karmanos Cancer Institute

News

McLaren Proceedings: Community

McLaren — We are our community To the communities we’re privileged to serve, McLaren is more than hospitals and off-site facilities. McLaren is th...

Read More

IN THE NEWS: The 5 best ways to slash your liver cancer risk, according to doctors

Best Life Liver cancer can be difficult to detect. Anthony Shields, M.D., Ph.D. , medical oncologist, leader of the Gastrointestinal and Neuroendo...

Read More

SoftVue(TM): Additional Screening Option for Women with Dense Breasts

WJR Natasha Robinette, M.D. , radiologist and clinical service chief of imaging at Karmanos Cancer Center , speaks with WJR's Lloyd Jackson about ...

Read More
News

SoftVue(TM): Additional Screening Option for Women with Dense Breasts | WJR's The Guy Gordon Show

Listen Now

ACS CAN Michigan Candid Connection, June 2022 - Cancer Survivorship

Listen Now

How a preemptive cancer screening helped save this doctor’s life

Listen Now